Acrivon Therapeutics OverviewAcrivon Therapeutics Other Income Expense Net
Other Income/Expense Net for ACRV.
Quarterly Other Income/Expense
$860000.00
↓ 56.61% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$5.09M
↓ 46.13% YoY
Trailing 12 months ending Mar 31, 2026